Deadly by Design
According to the CDC, 107,375 people in the United States died of drug overdoses and drug poisonings in the 12-month period ending in January 2022. A staggering 67 percent of those deaths involved synthetic opioids like fentanyl.1
All 50 states have reported adverse health effects in persons reporting synthetic cannabinoid use. These effects range from temporary changes in mental status to death.2
U-47700 ("Pinky") is 7 to 8 times more potent than morphine and can cause side effects, including coma and respiratory failure leading to death.3
1 “Fentanyl Awareness.” DEA, https://www.dea.gov/
2 “Synthetic Cannabinoids (SPICE): An Overview for Healthcare Providers.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 11 Apr. 2022, https://www.cdc.gov/nceh/hsb/
3 “47700.” U-47700, https://www.getsmartaboutdrugs. gov/drugs/u-47700
The dramatic rise of designer drugs in recent years has presented a significant
challenge to law enforcement and medical professionals in efforts to track and detect
these substances. The Designer Drug Panel available from Diax Labs allows clinicians
to detect a variety of designer drugs with a high level of sensitivity and specificity to
help prevent harmful drug interactions.
“Designer drugs” are substances created in environments free of legal and regulatory
controls, typically for the purpose of simulating the effects of a legal but controlled
substance. Since they are not subject to regulatory control until they are officially
identified as illegal drugs, designer drugs are initially sold legally online and in a
variety of retail outlets. Because designer drugs are constantly evolving to stay ahead
of the law, many lack consistency in their chemical structure and are not detected in
standard drug tests in the early stages of their distribution.
Our Designer Drug Panel provides results via a urine sample in 24 hours and tests for
the most current designer drugs, including Bath Salts.